SFX by Ex Libris Inc.

Title:	Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
Source:	Science [0036-8075] Pizza, M yr:2000

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Tettelin, H. "Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58." Science 287.5459 (2000): 1809-1815.
description	2.	SERRUTO, D. "The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens." Vaccine 30.2 (2012): -97.
description	3.	Westerink, M A A. "Novel vaccine strategies to T-independent antigens." Journal of microbiological methods 47.2 (2001): 135-49.
description	4.	Rappuoli, R. "Conjugates and reverse vaccinology to eliminate bacterial meningitis." Vaccine 19.17-19 (2001): 2319-22.
description	5.	Stephens, David S S. "Conquering the meningococcus." FEMS microbiology reviews 31.1 (2006): 3-14.
description	6.	Giuliani, Marzia M M. "A universal vaccine for serogroup B meningococcus." Proceedings of the National Academy of Sciences of the United States of America 103.Jul (2006): 10834-9.
description	7.	Gossger, N. "Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial." JAMA (Chicago, Ill.) 307.6 (2012): 573-582.
description	8.	Brandtzaeg, P. "Epidemic meningitis, meningococcaemia, and Neisseria meningitidis." Lancet, The 369.9580 (2007): 2196-210.
description	9.	Vipond, C. "History of meningococcal vaccines and their serological correlates of protection." Vaccine 30.Suppl. 2 (2012): -7.
description	10.	Parkhill, J. "Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491." Nature 404.6777 (2000): 502-6.
description	11.	Julius, M. "Thymus independent T cell development and selection in the intestinal epithelium." Annual review of immunology 12.1 (1994): 521-53.
description	12.	Vos, Q. "B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms." Immunological reviews 176.1: 154-170.
description	13.	Defrance, T. "T cell-independent B cell memory." Current opinion in immunology 23.3 (2011): 330-336.
description	14.	Pajon, R. "Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates." Vaccine 28.9 (2009): 2122-2129.
description	15.	Virji, M. "Pathogenic neisseriae: surface modulation, pathogenesis and infection control." Nature Reviews. Microbiology 7.4 (2009): 274-86.
description	16.	Harwood, Naomi E E. "New insights into the early molecular events underlying B cell activation." Immunity 28.5 (2008): 609-19.
description	17.	Schwartz, B S. "Global epidemiology of meningococcal disease." Clinical microbiology reviews 2.Suppl (1989): 118-24.
description	18.	Moran, Nancy A A. "Microbial minimalism: genome reduction in bacterial pathogens." Cell 108.5: 583-586.
description	19.	Keele, Brandon F. "Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1." Science 313.5786 (2006): 523-526.
description	20.	GOTSCHLI.EC, G. "HUMAN IMMUNITY TO MENINGOCOCCUS .3. PREPARATION AND IMMUNOCHEMICAL PROPERTIES OF GROUP A GROUP B AND GROUP C MENINGOCOCCAL POLYSACCHARIDES." The Journal of experimental medicine 129.6 (1969): 1349-.